Iran war impact
Based on the latest financial reports and industry context as of March 2026, the impact of the Iran-Israel conflict on Parmax Pharma Ltd. is categorized as Negative, primarily driven by rising operational costs and supply chain vulnerabilitie...
Read More
30.91
0.00
(0.00%)
42
BSE Volume
BSE 08 Apr, 2026 10:54 AM (IST)